B. Riley lowered the firm’s price target on Establishment Labs to $50 from $95 and keeps a Buy rating on the shares. Establishment reported a top line miss with sales below the Street’s expectations, and guidance cut to $165M from $200M-$210M, the analyst tells investors in a research note. While hard to gauge how long the slowed demand could last, particularly with distributors, management believes its generally transitory and short-lived and procedure demand should grow over time, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ESTA:
- JPMorgan ‘encouraged’ by Establishment Labs rally after Motiva China approval
- Establishment secures China NMPA approval for Motiva implants, says BTIG
- Establishment Labs price target lowered to $45 from $95 at BTIG
- Establishment Labs price target lowered to $50 from $80 at TD Cowen
- Establishment Labs price target lowered to $50 from $80 at Mizuho
Questions or Comments about the article? Write to editor@tipranks.com